Identification of candidate long noncoding RNAs associated with left ventricular hypertrophy

Clinical and Translational Science

Volumn 8, Issue 2, 2015, Pages 100-106

  Zhang, Lu ^a   Hamad, Eman A ^b   Vausort, Mélanie ^a   Funakoshi, Hajime ^c   Feldman, Arthur M ^b   Wagner, Daniel R ^a,d   Devaux, Yvan ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUKUOKA NATIONAL HOSPITAL   (Japan)

^d Hospital Center   (Luxembourg)

Author keywords

Adenosine; Cardiac hypertrophy; Cardioprotective molecules; Experimental disease model; Long noncoding RNAs; Microarrays

Indexed keywords

4 (4 CHLOROPHENYL) 2,3,9 TRIMETHYL 6H THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE 6 ACETIC ACID TERT BUTYL ESTER; ADENOSINE A2A RECEPTOR; LONG UNTRANSLATED RNA; TRANSCRIPTOME; CARDIOTONIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOME; HEART LEFT VENTRICLE HYPERTROPHY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHAM PROCEDURE; UPREGULATION; WILD TYPE; ANIMAL; AORTA; CHEMISTRY; DNA MICROARRAY; FACTUAL DATABASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; TRANSGENE; TRANSGENIC MOUSE;

ANIMALIA; MUS;

ANIMALS; AORTA; CARDIOTONIC AGENTS; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTOR, ADENOSINE A2A; RNA, LONG NONCODING; TRANSGENES;

EID: 84928015314     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/cts.12234     Document Type: Article

References (45)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature. Feb 15 2001; 409(6822): 860-921.
2. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. The sequence of the human genome. Science. Feb 16 2001; 291(5507): 1304-1351.
3. Consortium EP, Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. Sep 6 2012; 489(7414): 57-74.
4. Gurha P, Marian AJ. Noncoding RNAs in cardiovascular biology and disease. Circulation research. Dec 6 2013; 113(12): e115-e120.
5. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. Jun 8 2007; 316(5830): 1484-1488.
6. Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S, Pesce E, Ferrer I, Collavin L, Santoro C, et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. Nov 15 2012; 491(7424): 454-457.
7. Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, Shiekhattar R. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature. Feb 28 2013; 494(7438): 497-501.
8. Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. Mar 5 2013; 20(3): 300-307.
9. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 2011; 43(7): 621-629.
10. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6): 354-361.
11. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012; 9(6): 703-719.
12. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013; 339(2): 159-166.
13. Grote P, Wittler L, Hendrix D, Koch F, Wahrisch S, Beisaw A, Macura K, Blass G, Kellis M, Werber M, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. Jan 28 2013; 24(2): 206-214.
14. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey L, Haas S, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. Jan 31 2013; 152(3): 570-583.
15. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res. Oct 26 2012; 111(10): 1349-1362.
16. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. Jun 8 2007; 316(5830): 1491-1493.
17. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Human Genet. 2006; 51(12): 1087-1099.
18. Podlowski S, Bramlage P, Baumann G, Morano I, Luther HP. Cardiac troponin I sense-antisense RNA duplexes in the myocardium. J Cell Biochem. 2002; 85(1): 198-207.
19. Lee J-H, Gao C, Peng G, Greer C, Ren S, Wang Y, Xiao X. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. December 9 2011; 109(12): 1332-1341.
20. Chen J, Hsieh A, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010. Circulation. Nov 4 2013; 128(24): 2577-2584.
21. Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev. Drug Dis. 2013; 12(6): 433-446.
22. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J, Chen X, MacDonnell SM, Lee LL, Herrmann DE, Zhang J, et al. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation. Nov 21 2006; 114(21): 2240-2250.
23. Hamad EA, Zhu W, Chan TO, Myers V, Gao E, Li X, Zhang J, Song J, Zhang X-Q, Cheung JY, et al. Cardioprotection of controlled and cardiac-specific over-expression of A2A-adenosine receptor in the pressure overload. PLoS ONE. 2012; 7(7): e39919.
24. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. May 1 2005; 21(9): 2067-2075.
25. Anand P, Brown Jonathan D, Lin Charles Y, Qi J, Zhang R, Artero Pedro C, Alaiti MA, Bullard J, Alazem K, Margulies Kenneth B, et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell. 2013; 154(3): 569-582.
26. Delmore Jake E, Issa Ghayas C, Lemieux Madeleine E, Rahl Peter B, Shi J, Jacobs Hannah M, Kastritis E, Gilpatrick T, Paranal Ronald M, Qi J, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011; 146(6): 904-917.
27. Spiltoir JI, Stratton MS, Cavasin MA, Demos-Davies K, Reid BG, Qi J, Bradner JE, McKinsey TA. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J Mol Cell Cardiol. 2013; 63(0): 175-179.
28. Liao Q, Xiao H, Bu D, Xie C, Miao R, Luo H, Zhao G, Yu K, Zhao H, Skogerbo G, et al. ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res. 2011; 39(Web Server issue): W118-W124.
29. Michelhaugh SK, Lipovich L, Blythe J, Jia H, Kapatos G, Bannon MJ. Mining affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers. J Neurochem. Feb 2011; 116(3): 459-466.
30. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al. The transcriptional landscape of the mammalian genome. Science. Sep 2 2005; 309(5740): 1559-1563.
31. Yamasaki C, Murakami K, Fujii Y, Sato Y, Harada E, Takeda J, Taniya T, Sakate R, Kikugawa S, Shimada M, et al. The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts. Nucleic Acids Res. Jan 2008; 36(Database issue): D793-D799.
32. Pang KC, Stephen S, Engstrom PG, Tajul-Arifin K, Chen W, Wahlestedt C, Lenhard B, Hayashizaki Y, Mattick JS. RNAdb-a comprehensive mammalian noncoding RNA database. Nucleic Acids Res. Jan 1 2005; 33(Database issue): D125-D130.
33. Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res. Jan 2011; 39(Database issue): D146-D151.
34. Pruitt KD, Tatusova T, Maglott DR. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. Jan 1 2005; 33(Database issue): D501-D504.
35. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, Cox T, Cuff J, Curwen V, Down T, et al. The Ensembl genome database project. Nucleic Acids Res. Jan 1 2002; 30(1): 38-41.
36. Gellert P, Ponomareva Y, Braun T, Uchida S. Noncoder: a web interface for exon array-based detection of long non-coding RNAs. Nucleic Acids Res. Jan 7 2013; 41(1): e20.
37. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST, Leung GK. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012; 48(1): 1-8.
38. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, Chen Y, Liu XS. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol. Jul 2013; 20(7): 908-913.
39. Bousquenaud M, Maskali F, Poussier S, Zangrando J, Marie PY, Boutley H, Fay R, Karcher G, Wagner DR, Devaux Y. Cardioprotective effects of adenosine within the border and remote areas of myocardial infarction. EJNMMI Res. 2013; 3(1): 65.
40. Ernens I, Rouy D, Velot E, Devaux Y, Wagner DR. Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2A receptor and cAMP/PKA/Ca2+ pathway. Circ Res. Sep 15 2006; 99(6): 590-597.
41. Haas B, Leonard F, Ernens I, Rodius S, Vausort M, Rolland-Turner M, Devaux Y, Wagner DR. Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products. J Cardiovasc Transl Res. Dec 2011; 4(6): 790-800.
42. Leonard F, Devaux Y, Vausort M, Ernens I, Rolland-Turner M, Wagner DR. Adenosine modifies the balance between membrane and soluble forms of Flt-1. J Leukoc Biol. Mar 29 2011; 90(1): 199-204.
43. Chan TO, Funakoshi H, Song J, Zhang XQ, Wang J, Chung PH, DeGeorge BR, Jr., Li X, Zhang J, Herrmann DE, et al. Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor. Clin Transl Sci. Sep 2008; 1(2): 126-133.
44. Hamad EA, Li X, Song J, Zhang X-Q, Myers V, Funakoshi H, Zhang J, Wang J, Li J, Swope D, et al. Effects of cardiac-restricted overexpression of the A2A adenosine receptor on adriamycin-induced cardiotoxicity. Am J Physiol. June 1, 2010; 298(6): H1738-H1747.
45. Yang KC, Yamada KA, Patel AY, Topkara VK, George I, Cheema FH, Ewald GA, Mann DL, Nerbonne JM. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNA in failing human heart and remodeling with mechanical circulatory support. Circulation. Jan 15 2014; 129(9): 1009-1021.